美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

文艺复兴科技持仓

1,950.37

-4.1689-0.21%

涨家数：68

跌家数：27

平家数：1

市盈率：- -

高：1,957.47

开：1,951.40

低：1,933.53

收：1,954.54

数据加载中...

Septerna盘前大涨70%！诺和诺德口服小分子减肥药牵手成功

BUZZ-先进微器件公司跳涨，宣布新的 60 亿美元股票回购计划

AMD股价美股盘前涨逾5%

每日经济新闻

BUZZ-Exelixis上调2025年收入预期后股价上涨

AMD 宣布新的 60 亿美元股票回购计划

AMD(AMD.O)：将回购最多60亿美元的股票。

诺和诺德达成口服小分子药物新合作，总额约22亿美元

BUZZ-中美紧张局势缓解削弱金银避险吸引力，黄金矿商下跌

盘前异动 | Septerna暴涨63%，将与诺和诺德合作开发口服减肥药

美股异动 | Septerna(SEPN.US)盘前大涨67% 将与诺和诺德合作开发口服减肥药

智通财经网

诺和诺德与Septerna达成22亿美元协议共同开发新一代减重口服药

Septerna盘前涨超65% 与诺和诺德合作开发针对肥胖及其他心代谢疾病的口服小分子药物

诺和诺德达成22亿美元交易开发新型减重疗法

诺和诺德(NVO)盘前升近2% 诺和诺德中国与平安好医生达成战略合作

诺和诺德达成22亿美元合作，剑指多靶点口服小分子

医药魔方Info

诺和诺德与美国生物技术公司Septerna达成合作许可协议，将共同开发肥胖症等疾病药物

联合健康(UNH.US)新CEO基本年薪为100万美元远低于前任

诺和诺德与Septerna达成22亿美元协议共同开发新型肥胖症治疗方法

新款蔚来ES6 EC6实车曝光或将于5-6月正式亮相

人工智能基础设施公司 TensorWave 最新融资 1 亿美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4532/news?page=8"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4532","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4532\",,,,,undefined,":{"symbol":"BK4532","market":"US","secType":"PLATE","nameCN":"文艺复兴科技持仓","latestPrice":1950.37,"timestamp":1747339199999,"preClose":1954.539,"halted":0,"volume":1065251631,"delay":0,"changeRate":-0.002133,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-4.168945,"latestTime":"05-15 16:00:00 EDT","open":1951.4016,"high":1957.474,"low":1933.5256,"amount":149444442435.57565,"amplitude":0.012253,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1747353600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.449547,"peRate":28.712379,"turnoverRate":0.008391,"increases":68,"decrements":27,"flats":0,"marketCap":21673993282752,"floatMarketCap":20274745426000},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4532\",,,,,undefined,":{"symbol":"BK4532","high":1957.474,"amplitude":0.012253,"preClose":1954.539,"low":1933.5256,"pbRate":"8.449547","latestPrice":1950.37,"volume":1065251631,"delay":0,"open":1951.4016,"prevYearClose":2026.1482,"prevWeekClose":1842.5564,"prevMonthClose":1815.0321,"prevQuarterClose":1820.2863,"fiveDayClose":1845.5483,"twentyDayClose":1727.4802,"sixtyDayClose":2068.769,"secType":"PLATE","market":"US","turnoverRate":0.008391,"peRate":28.712379,"marketCap":21673993282752,"floatMarketCap":20274745426000,"timestamp":1747339199999,"nameCN":"文艺复兴科技持仓"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4532\",,,,undefined,":{"bkCode":"BK4532","up":68,"down":27,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4532\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2535288663","title":"Septerna盘前大涨70%！诺和诺德口服小分子减肥药牵手成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2535288663","media":"Jo的随笔","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535288663?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 21:22","pubTimestamp":1747228921,"startTime":"0","endTime":"0","summary":"诺和诺德最终在小分子口服减肥药赛道，选择了Septerna。根据协议，Septerna 将从诺和诺德获得约 22 亿美元预付款及研发和商业里程碑付款，其中包括超 2 亿美元的预付款和近期里程碑付款。此外，Septerna 还将获得已上市产品全球净销售额的分级特许权使用费。Septerna 有权选择参与合作中一项项目的全球利润分成，替代该产品候选物未来的里程碑付款和特许权使用费。歌礼all in小分子口服减肥药，高剂量临床结果呼之欲出！","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515055837a47ea9cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515055837a47ea9cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVO","IE00BZ1G4Q59.USD","LU0154236417.USD","LU1093756325.SGD","SEPN","BK4599","BK4585","BK4588","IE00BKVL7J92.USD","LU1093756168.USD","BK4532","BK4007"],"gpt_icon":1},{"id":"2535240770","title":"BUZZ-先进微器件公司跳涨，宣布新的 60 亿美元股票回购计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2535240770","media":"路透中文","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535240770?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 21:10","pubTimestamp":1747228200,"startTime":"0","endTime":"0","summary":"BUZZ-先进微器件公司跳涨，宣布新的 60 亿美元股票回购计划5月14日 - ** 先进微设备公司AMD.O股价盘前上涨5.7%至119.02美元** AMD宣布新的60亿美元股票回购计划   ** 公司称，新的授权是对截至 3 月 29 日约 40 亿美元余额的补充。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2002e7c41b0fd3e91e69d7effa2fd7ba","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL4S3RM173:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE0004445239.USD","LU2458330169.SGD","BK4529","LU0082616367.USD","LU0823421333.USD","BK4532","LU1951200564.SGD","LU2098885051.SGD","LU0979878070.USD","IE00B5949003.HKD","BK4573","BK4575","BK4612","LU0390134368.USD","LU1852331112.SGD","LU1303367103.USD","LU1923623000.USD","LU1064131342.USD","LU1880398554.USD","BK4141","LU0127658192.USD","BK4605","LU1316542783.SGD","LU2360106780.USD","AMD","LU0719512351.SGD","IE00BMPRXN33.USD","LU2264538146.SGD","LU0889565833.HKD","BK4512","BK4614","IE0009356076.USD","LU0823434740.USD","LU0198837287.USD","LU0056508442.USD","LU1951198990.SGD","LU0823421416.USD","LU2458330243.SGD","LU1803068979.SGD","BK4534","LU0109392836.USD","LU0823434583.USD","LU2054465674.USD","LU1988902786.USD","LU1242518857.USD","IE00BMPRXR70.SGD","BK4585","BK4554","BK4543"],"gpt_icon":0},{"id":"2535977022","title":"AMD股价美股盘前涨逾5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535977022","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535977022?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 21:05","pubTimestamp":1747227933,"startTime":"0","endTime":"0","summary":"AMD股价美股盘前涨逾5%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://stock.eastmoney.com/a/202505143404628581.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/a/202505143404628581.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1923623000.USD","LU0979878070.USD","LU1951200564.SGD","IE00BMPRXR70.SGD","LU1316542783.SGD","BK4141","LU1303367103.USD","LU2458330243.SGD","LU2098885051.SGD","LU0642271901.SGD","LU0823434583.USD","LU1951198990.SGD","LU2054465674.USD","LU0056508442.USD","LU0823434740.USD","BK4534","BK4512","LU0109392836.USD","LU1880398554.USD","LU0719512351.SGD","IE0009356076.USD","BK4554","LU0390134368.USD","BK4543","GFS","BK4588","LU1989764664.SGD","BK4612","LU0823421333.USD","LU1880398471.USD","LU2250418816.HKD","IE0004445239.USD","LU1803068979.SGD","LU0889565833.HKD","LU1242518857.USD","LU0823421416.USD","IE00BMPRXN33.USD","LU1988902786.USD","IE00B5949003.HKD","BK4614","LU2264538146.SGD","LU2360106780.USD","AMD","BK4532","LU0127658192.USD","LU1852331112.SGD","BK4585","LU0198837287.USD","BK4605","BK4566"],"gpt_icon":0},{"id":"2535242060","title":"BUZZ-Exelixis上调2025年收入预期后股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2535242060","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535242060?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 21:05","pubTimestamp":1747227916,"startTime":"0","endTime":"0","summary":"BUZZ-Exelixis上调2025年收入预期后股价上涨5月14日 - ** 癌症药物制造商ExelixisEXEL.O股价盘前上涨5.6%至39美元** 该公司在周二晚些时候将2025年的营收预期上调至22.5亿至23.5亿美元，之前的预期为21.5亿至22.5亿美元。** 截至上次收盘，股价累计上涨 11 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL4S3RM16K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","BK4532","BK4139"],"gpt_icon":0},{"id":"2535024172","title":"AMD 宣布新的 60 亿美元股票回购计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2535024172","media":"路透中文","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535024172?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 21:03","pubTimestamp":1747227828,"startTime":"0","endTime":"0","summary":"AMD 宣布新的 60 亿美元股票回购计划路透5月14日 - 芯片巨头AMD(超威/超微) AMD.O周三表示，公司董事会已经批准了一项新的60亿美元的股票回购计划，从而将公司的股票回购授权总额提高到约100亿美元。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL4T3RM16C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989764664.SGD","LU1064131342.USD","BK4554","LU0823421333.USD","BK4588","LU2458330243.SGD","BK4532","LU1852331112.SGD","IE00B5949003.HKD","LU0198837287.USD","BK4529","LU2054465674.USD","LU0081259029.USD","IE0009356076.USD","BK4512","BK4612","LU0979878070.USD","LU1951200564.SGD","LU1988902786.USD","BK4585","BK4605","IE00BMPRXN33.USD","LU0642271901.SGD","LU2458330169.SGD","IE00BMPRXR70.SGD","BK4566","BK4141","LU0719512351.SGD","LU1316542783.SGD","LU1880398471.USD","BK4534","LU0823434740.USD","BK4575","AMD","LU1803068979.SGD","LU2360106780.USD","LU1242518857.USD","LU0390134368.USD","LU0109392836.USD","LU0056508442.USD","BK4543","LU0823421416.USD","LU1880398554.USD","IE0004445239.USD","LU2250418816.HKD","LU1242518931.SGD","LU1923623000.USD","BK4573","LU0889565833.HKD","LU2264538146.SGD"],"gpt_icon":0},{"id":"2535249250","title":"AMD(AMD.O)：将回购最多60亿美元的股票。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535249250","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535249250?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 21:00","pubTimestamp":1747227637,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"faa7ab872ee8caf59b3e74c50ca94186","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4612","LU0198837287.USD","LU0979878070.USD","AMD","LU1316542783.SGD","LU1242518931.SGD","LU0719512351.SGD","IE00BMPRXN33.USD","LU0823421333.USD","LU0056508442.USD","BK4543","BK4588","BK4141","LU1880398554.USD","LU1923623000.USD","LU1803068979.SGD","LU1988902786.USD","BK4614","GFS","LU0823421416.USD","BK4585","BK4534","LU0109392836.USD","LU0390134368.USD","LU1880398471.USD","LU0642271901.SGD","LU2264538146.SGD","LU1303367103.USD","LU0127658192.USD","LU1242518857.USD","LU2360106780.USD","LU1951198990.SGD","LU0081259029.USD","BK4554","LU2458330169.SGD","LU1064131342.USD","BK4573","LU2458330243.SGD","LU2250418816.HKD","LU0823434583.USD","LU0889565833.HKD","LU0823434740.USD","BK4532","BK4575","LU2054465674.USD","IE0004445239.USD","LU0082616367.USD","BK4605","BK4566","LU1989764664.SGD"],"gpt_icon":0},{"id":"2535102476","title":"诺和诺德达成口服小分子药物新合作，总额约22亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535102476","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535102476?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 21:00","pubTimestamp":1747227623,"startTime":"0","endTime":"0","summary":"本文来源：时代财经5月14日，时代财经获悉，诺和诺德对外宣布，与Septerna达成一项独家全球合作及许可协议，双方将共同致力于发现、开发并商业化针对肥胖症、2型糖尿病及其他心脏代谢疾病的口服小分子药物。根据协议条款，Septerna将有资格从诺和诺德获得总计约22亿美元的付款，其中有超2亿美元为预付款及近期里程碑付款。Septerna还可获得上市产品的分层特许权使用费。另外，据悉，诺和诺德将承担合作项目的全部研发费用。（时代财经 张羽岐）","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421021094f6c08a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421021094f6c08a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVO","IE00BZ1G4Q59.USD","LU0154236417.USD","LU1093756325.SGD","BK4599","BK4585","BK4588","IE00BKVL7J92.USD","LU1093756168.USD","BK4532","BK4007"],"gpt_icon":0},{"id":"2535021524","title":"BUZZ-中美紧张局势缓解削弱金银避险吸引力，黄金矿商下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2535021524","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535021524?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 20:43","pubTimestamp":1747226638,"startTime":"0","endTime":"0","summary":"** 加拿大矿商Kinross Gold KGC.N和Agnico Eagle Mines AEM.N分别下跌1.3%和1%。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL4S3RM156:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4017","LU0075056555.USD","LU0456854461.SGD","BK4570","LU1023059493.AUD","LU0788108826.HKD","LU0654597011.USD","LU0724618789.USD","LU0300736062.USD","LU1223083913.SGD","LU0788109121.HKD","LU2498475776.HKD","BK4585","LU0278409577.USD","LU0266512127.USD","LU1883866441.USD","LU0345780521.USD","LU0368265764.SGD","BK4533","LU1430597077.USD","LU0345780281.USD","NEM","LU1223082196.USD","LU0612318971.USD","SG9999001143.SGD","LU0496367417.USD","LU1223082519.USD","LU2462611646.USD","BK4532","LU0330918003.SGD","LU1280957306.USD","LU0300736492.USD","LU0498741890.SGD","LU0640476718.USD","LU0498741114.HKD","LU0612318385.USD","BK4588","LU0055631609.USD"],"gpt_icon":0},{"id":"2535029024","title":"盘前异动 | Septerna暴涨63%，将与诺和诺德合作开发口服减肥药","url":"https://stock-news.laohu8.com/highlight/detail?id=2535029024","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535029024?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 20:42","pubTimestamp":1747226528,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺和诺德同意与Septerna共同开发和商业化用于治疗肥胖症和其他心脏代谢疾病的口服小分子药物，交易价值高达22亿美元。受该消息影响，Septerna盘前大涨67%。作为交易的一部分，该公司将从诺和诺德获得超过2亿美元的预付款和近期里程碑付款。诺和诺德向Septerna支付的总金额可能达到22亿美元，包括预付款以及研发和商业里程碑付款。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"30e0cbc36438ac0be975e41ae2b7cc35","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1293255.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Septerna将与诺和诺德合作开发口服减肥药","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","NVO","IE00BZ1G4Q59.USD","BK4532","LU0154236417.USD","IE00BKVL7J92.USD","LU1093756168.USD","SEPN","BK4007","BK4585","LU1093756325.SGD","BK4599"],"gpt_icon":0},{"id":"2535602161","title":"美股异动 | Septerna(SEPN.US)盘前大涨67% 将与诺和诺德合作开发口服减肥药","url":"https://stock-news.laohu8.com/highlight/detail?id=2535602161","media":"智通财经网","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535602161?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 20:34","pubTimestamp":1747226040,"startTime":"0","endTime":"0","summary":"诺和诺德同意与Septerna共同开发和商业化用于治疗肥胖症和其他心脏代谢疾病的口服小分子药物，交易价值高达22亿美元。受该消息影响，Septerna盘前大涨67%。作为交易的一部分，该公司将从诺和诺德获得超过2亿美元的预付款和近期里程碑付款。诺和诺德向Septerna支付的总金额可能达到22亿美元，包括预付款以及研发和商业里程碑付款。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-05-14/doc-inewpwew0285573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BZ1G4Q59.USD","LU0154236417.USD","LU1093756325.SGD","SEPN","BK4599","BK4585","BK4588","IE00BKVL7J92.USD","LU1093756168.USD","BK4532","BK4007"],"gpt_icon":1},{"id":"2535211680","title":"诺和诺德与Septerna达成22亿美元协议 共同开发新一代减重口服药","url":"https://stock-news.laohu8.com/highlight/detail?id=2535211680","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535211680?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 20:32","pubTimestamp":1747225926,"startTime":"0","endTime":"0","summary":"格隆汇5月14日｜诺和诺德周三宣布，与美国生物技术公司Septerna达成价值高达22亿美元的合作与授权协议，将共同开发针对肥胖、第二型糖尿病及其他心脏代谢疾病的口服小分子新药。这笔交易包含超过2亿美元的预付款及短期付款，未来潜在价值最高可达22亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514203218975976fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"30e0cbc36438ac0be975e41ae2b7cc35","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514203218975976fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0154236417.USD","BK4585","IE00BKVL7J92.USD","BK4599","LU1093756168.USD","NVO","BK4588","BK4007","IE00BZ1G4Q59.USD","LU1093756325.SGD","SEPN","BK4532"],"gpt_icon":0},{"id":"2535298400","title":"Septerna盘前涨超65% 与诺和诺德合作开发针对肥胖及其他心代谢疾病的口服小分子药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2535298400","media":"金吾资讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535298400?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 20:20","pubTimestamp":1747225205,"startTime":"0","endTime":"0","summary":"金吾财讯 | Septerna(SEPN)盘前股价暴力拉升，暂涨65.92%，报11.16美元。消息面上，公司与诺和诺德达成合作与许可协议，共同开发用于治疗肥胖症、2型糖尿病和其他心脏代谢疾病的口服小分子药物。诺和诺德是广受欢迎的减肥药Wegovy的制造商，该公司试图通过开发下一代药物、收购和合作来进一步巩固其在潜在的1500亿美元肥胖症市场中的地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051420204294f6b68a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"30e0cbc36438ac0be975e41ae2b7cc35","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051420204294f6b68a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVO","BK4007","BK4585","LU0154236417.USD","LU1093756325.SGD","LU1093756168.USD","BK4532","BK4588","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","SEPN","BK4599"],"gpt_icon":0},{"id":"2535276230","title":"诺和诺德达成22亿美元交易 开发新型减重疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2535276230","media":"第一财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535276230?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 20:07","pubTimestamp":1747224461,"startTime":"0","endTime":"0","summary":"【诺和诺德达成22亿美元交易 开发新型减重疗法】欧洲当地时间5月14日，诺和诺德宣布，已与美国生物技术公司Septerna达成合作及许可协议，共同开发用于治疗肥胖症、2型糖尿病和其他心脏代谢疾病的口服小分子药物，该协议价值预计高达22亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202505143404602184.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505143404602184.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4532","BK4588","LU1093756168.USD","BK4585","BK4007","LU0154236417.USD","LU1093756325.SGD","NVO","IE00BZ1G4Q59.USD","BK4599","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2535255730","title":"诺和诺德(NVO)盘前升近2% 诺和诺德中国与平安好医生达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2535255730","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535255730?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 19:56","pubTimestamp":1747223800,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺和诺德(NVO)盘前股价走高，暂升1.94%，报66.67美元。平安好医生(01833.HK)与诺和诺德中国宣布达成战略合作，双方将结合在肥胖症管理及公众健康教育领域的各自优势，共同构建覆盖“认知提升—诊疗干预—长期管理”的全周期服务闭环，推动科学减重理念。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/Mjg1NzQ1OGJhMDJiZWVjMjcxYjFlYjJjMTY3ODIxNTA4Njc=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/Mjg1NzQ1OGJhMDJiZWVjMjcxYjFlYjJjMTY3ODIxNTA4Njc=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"288505","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1571","BK1617","BK4585","BK4532","LU1093756168.USD","BK4588","LU1093756325.SGD","BK1615","BK1515","IE00BZ1G4Q59.USD","BK1247","LU0154236417.USD","01833","BK4599","BK4007","BK1142","BK1219","IE00BKVL7J92.USD","NVO"],"gpt_icon":0},{"id":"2535275460","title":"诺和诺德达成22亿美元合作，剑指多靶点口服小分子","url":"https://stock-news.laohu8.com/highlight/detail?id=2535275460","media":"医药魔方Info","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535275460?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 19:53","pubTimestamp":1747223597,"startTime":"0","endTime":"0","summary":"5月14日，诺和诺德与Septerna宣布达成一项独家全球合作及许可协议，双方将共同致力于发现、开发并商业化针对肥胖症、2型糖尿病及其他心脏代谢疾病的口服小分子药物。根据协议条款，Septerna将有资格从诺和诺德获得总计约22亿美元的付款，包括首付款及研发、商业化里程碑款项，其中超过2亿美元为预付款及近期里程碑付款。自IND申报阶段起，诺和诺德将独家负责全球开发及商业化工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514211119a47e393d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514211119a47e393d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0154236417.USD","LU1093756168.USD","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4599","IE00BKVL7J92.USD","BK4007","NVO","BK4588","BK4532","BK4585"],"gpt_icon":0},{"id":"2535025717","title":"诺和诺德与美国生物技术公司Septerna达成合作许可协议，将共同开发肥胖症等疾病药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2535025717","media":"界面","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535025717?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 19:53","pubTimestamp":1747223589,"startTime":"0","endTime":"0","summary":"5月14日，诺和诺德公司宣布，其与美国生物技术公司Septerna达成了一项合作与许可协议，将共同开发治疗肥胖症、2型糖尿病和其他心血管疾病的口服小分子药物。诺和诺德表示，Septerna公司将有资格获得约22亿美元的收益，其中包括超2亿美元的前期和近期付款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514195309a6deea57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"30e0cbc36438ac0be975e41ae2b7cc35","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514195309a6deea57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","LU0154236417.USD","BK4532","IE00BZ1G4Q59.USD","LU1093756168.USD","SEPN","BK4585","LU1093756325.SGD","BK4588","NVO","IE00BKVL7J92.USD","BK4007"],"gpt_icon":0},{"id":"2535025589","title":"联合健康(UNH.US)新CEO基本年薪为100万美元 远低于前任","url":"https://stock-news.laohu8.com/highlight/detail?id=2535025589","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535025589?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 19:49","pubTimestamp":1747223377,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，联合健康周三公布新任首席执行官Stephen Hemsley的基本年薪将为100万美元，在此之前，该公司宣布Andrew Witty因个人原因辞去首席执行官一职。现年72岁的Hemsley担任该公司的董事会主席，并曾经担任首席执行官。在Witty周一突然离职后，Hemsley被联合健康任命为首席执行官，任命立即生效。尽管Hemsley同时担任联合健康董事长和首席执行官，但他将不再以董事身份领取薪酬。Witty在2024年的基本工资为150万美元。截至发稿，联合健康盘前涨2.2%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3a8730fee8191154e1f1a3043d05ab53","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1293220.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2236285917.USD","LU1023059063.AUD","LU0149725797.USD","LU0029864427.USD","BK4585","IE00B19Z8W00.USD","LU1670628061.USD","IE00B2B36J28.USD","SG9999013999.USD","IE00B1XK9C88.USD","LU0965508806.USD","IE0002141913.USD","LU1934455194.USD","LU2112291526.USD","LU2089284900.SGD","LU2244417387.USD","IE00B19Z3B42.SGD","LU0052756011.USD","IE00BN29S564.USD","LU0943347566.SGD","LU1551013342.USD","LU1670627923.USD","LU0820561818.USD","LU2133065610.SGD","LU0672654240.SGD","LU1261432733.SGD","LU2089283258.USD","LU0077335932.USD","IE00BFSS7M15.SGD","LU0011850046.USD","IE00B19Z9505.USD","IE00B19Z3581.USD","LU1035773651.USD","LU1267930730.SGD","LU0211326755.USD","BK4532","LU0708994859.HKD","LU0795875169.SGD","IE00BFXG1179.USD","LU0109391861.USD","LU1066051225.USD","IE0004445015.USD","IE00B7KXQ091.USD","LU1720051108.HKD","SG9999014898.SGD","LU0683600562.USD","LU1674673428.USD","LU1720051017.SGD","UNH","IE00BJT1NW94.SGD"],"gpt_icon":1},{"id":"2535461023","title":"诺和诺德与Septerna达成22亿美元协议 共同开发新型肥胖症治疗方法","url":"https://stock-news.laohu8.com/highlight/detail?id=2535461023","media":"金吾资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535461023?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 19:42","pubTimestamp":1747222978,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺和诺德(NVO)周三表示，已与美国生物技术公司Septerna达成合作与许可协议，共同开发用于治疗肥胖症、2型糖尿病和其他心脏代谢疾病的口服小分子药物。诺和诺德是广受欢迎的减肥药Wegovy的制造商，该公司试图通过开发下一代药物、收购和合作来进一步巩固其在潜在的1500亿美元肥胖症市场中的地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051419444594f6ae1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"30e0cbc36438ac0be975e41ae2b7cc35","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051419444594f6ae1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","NVO","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4585","SEPN","IE00BKVL7J92.USD","LU0154236417.USD","BK4007","BK4532","LU1093756168.USD","BK4588"],"gpt_icon":0},{"id":"2535074297","title":"新款蔚来ES6 EC6实车曝光 或将于5-6月正式亮相","url":"https://stock-news.laohu8.com/highlight/detail?id=2535074297","media":"车评网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535074297?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 19:00","pubTimestamp":1747220415,"startTime":"0","endTime":"0","summary":"近日，一组新款蔚来ES6和EC6的实车谍照在网络上曝光，引发业界关注。据知情人士透露，新车将基于升级后的NT2.5平台打造，预计最快将于今年第二季度正式上市。现款ES6和EC6均搭载前后双电机系统，前电机最大功率150千瓦，后电机最大功率210千瓦，综合输出功率达490马力，峰值扭矩700牛·米。续航方面提供75kWh、100kWh和150kWh三种电池组选择，现款ES6的CLTC续航里程分别为500公里、625公里和930公里，EC6则为505公里、630公里和935公里。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514231752a47e550f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514231752a47e550f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320764599.SGD","BK4531","BK4526","BK4574","09866","BK4548","NIO","BK4505","BK4099","BK4509","BK4555","BK4504","BK4588","BK4581","NIO.SI","EVS.SI","BK4585","LU0052750758.USD","LU0708995583.HKD","BK4532","BK4534"],"gpt_icon":1},{"id":"2535939042","title":"人工智能基础设施公司 TensorWave 最新融资 1 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535939042","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535939042?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 19:00","pubTimestamp":1747220413,"startTime":"0","endTime":"0","summary":"人工智能基础设施公司 TensorWave 最新融资 1 亿美元路透5月14日 - 总部位于拉斯维加斯的初创公司 TensorWave 周三宣布，该公司在最新一轮融资中获得了 1 亿美元的资金，目的是利用迅速扩大的人工智能基础设施市场。\"该公司表示：\"此次融资正值人工智能基础设施市场经历前所未有的增长之际，最近的行业报告预计，到2027年，人工智能基础设施市场将超过4000亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL4T3RM0ZT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1988902786.USD","LU2054465674.USD","BK4141","LU1242518931.SGD","LU0719512351.SGD","LU0109392836.USD","IE0009356076.USD","LU0979878070.USD","LU1989764664.SGD","BK4588","LU1880398471.USD","LU1951200564.SGD","LU0198837287.USD","LU0823421416.USD","LU1951198990.SGD","BK4575","LU1064131342.USD","IE00BMPRXR70.SGD","LU0889565833.HKD","LU2250418816.HKD","LU0082616367.USD","LU2458330169.SGD","BK4534","BK4532","LU0056508442.USD","LU1880398554.USD","LU2098885051.SGD","LU0081259029.USD","BK4612","LU2264538146.SGD","LU1852331112.SGD","LU0823434583.USD","BK4554","BK4543","LU2458330243.SGD","BK4512","LU1923623000.USD","BK4573","BK4605","LU0823434740.USD","LU1316542783.SGD","LU2360106780.USD","BK4614","IE00BMPRXN33.USD","LU0127658192.USD","LU0390134368.USD","AMD","LU1303367103.USD","BK4566","LU0642271901.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":46,"pageCount":8,"totalSize":905,"code":"91000000","status":"200"}]}}